16-177059-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PM2PP3_StrongBP6

The NM_000558.5(HBA1):​c.226G>T​(p.Asp76Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000861 in 1,510,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D76A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000088 ( 0 hom. )

Consequence

HBA1
NM_000558.5 missense

Scores

9
2
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1O:1

Conservation

PhyloP100: -0.0490
Variant links:
Genes affected
HBA1 (HGNC:4823): (hemoglobin subunit alpha 1) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
BP6
Variant 16-177059-G-T is Benign according to our data. Variant chr16-177059-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 15834.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA1NM_000558.5 linkc.226G>T p.Asp76Tyr missense_variant Exon 2 of 3 ENST00000320868.9 NP_000549.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA1ENST00000320868.9 linkc.226G>T p.Asp76Tyr missense_variant Exon 2 of 3 1 NM_000558.5 ENSP00000322421.5 P69905
HBA1ENST00000472694.1 linkn.362G>T non_coding_transcript_exon_variant Exon 1 of 2 1
HBA1ENST00000487791.1 linkn.195G>T non_coding_transcript_exon_variant Exon 2 of 2 1
HBA1ENST00000397797.1 linkc.130G>T p.Asp44Tyr missense_variant Exon 2 of 3 2 ENSP00000380899.1 G3V1N2

Frequencies

GnomAD3 genomes
AF:
0.00000665
AC:
1
AN:
150394
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000149
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000882
AC:
12
AN:
1359774
Hom.:
0
Cov.:
25
AF XY:
0.00000890
AC XY:
6
AN XY:
674410
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000399
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000950
Gnomad4 OTH exome
AF:
0.0000175
GnomAD4 genome
AF:
0.00000665
AC:
1
AN:
150394
Hom.:
0
Cov.:
31
AF XY:
0.0000136
AC XY:
1
AN XY:
73284
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000149
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Aug 07, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The Hb Winnipeg variant (HBA1: c.226G>T; p.Asp76Tyr, also known as Asp75Tyr when numbered from the mature protein, rs33977363, HbVar ID: 113) is reported in the literature in multiple individuals with no clinical symptoms and does not contribute to the clinical phenotype when found with the 3.7kb alpha globin deletion (Nakatsuji 1983, Moradkhani 2009, HbVar database and references therein). This variant is reported in ClinVar (Variation ID: 15834) but is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.751), though functional properties of Hb Winnipeg are reported as normal and stable (Nakatsuji 1983, Moradkhani 2009, HbVar database and references therein). Based on available information, this variant is considered to be likely benign. REFERENCES Link to HbVar: https://globin.bx.psu.edu/hbvar/hbvar.html Moradkhani K et al. Mutations in the paralogous human alpha-globin genes yielding identical hemoglobin variants. Ann Hematol. 2009 Jun;88(6):535-43. PMID: 18923834. Nakatsuji T et al. Hb Winnipeg or alpha 2 75(EF4) Asp leads to Tyr beta 2 in a large Caucasian family living in Georgia, USA. Hemoglobin. 1983;7(1):105-10. PMID: 6841125. -

Feb 09, 2024
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The HBA1 c.226G>T (p.Asp76Tyr) variant (also known as Hb Winnipeg) has been described to have normal stability and oxygen affinity (PMID: 6841125 (1983)). Individuals who are heterozygous for this variant have a normal clinical presentation (PMIDs: 6841125 (1983), 4728965 (1973)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, we are unable to determine the clinical significance of this variant. -

HEMOGLOBIN WINNIPEG Other:1
Jul 20, 2016
OMIM
Significance: other
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.43
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.37
T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.69
T;T
M_CAP
Pathogenic
0.75
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.71
D
PrimateAI
Uncertain
0.61
T
PROVEAN
Pathogenic
-7.5
D;D
REVEL
Pathogenic
0.75
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0010
D;D
Vest4
0.88
MutPred
0.97
Loss of disorder (P = 0.0205);.;
MVP
1.0
ClinPred
1.0
D
GERP RS
2.3
Varity_R
0.97
gMVP
0.94

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs33977363; hg19: chr16-227058; API